[
    [
        {
            "time": "2023-10-01",
            "original_text": "US STOCKS-S&P 500, Nasdaq reach record closing highs; Chinese workers return",
            "features": {
                "keywords": [
                    "record highs",
                    "Nasdaq",
                    "Chinese workers"
                ],
                "sentiment_score": 0.9,
                "policy_related": "false",
                "investment_strategy": "false",
                "sector_focus": [
                    "finance",
                    "technology"
                ],
                "causal_factor": "true",
                "causal_impact": "positive",
                "affected_by_time_series": "false",
                "ts_effect_direction": "neutral"
            },
            "scores": {
                "News_content": "US STOCKS-S&P 500, Nasdaq reach record closing highs; Chinese workers return",
                "Correlation": 9,
                "Sentiment": 8,
                "Importance": 8,
                "Impact": 7,
                "Duration": 6,
                "Entity_Density": 4,
                "Market_Scope": 9,
                "Time_Proximity": 8,
                "Headline_Structure": 7,
                "Source_Recency": 8
            }
        },
        {
            "time": "2023-10-02",
            "original_text": "US STOCKS-Nasdaq hits new high as investors look beyond coronavirus",
            "features": {
                "keywords": [
                    "Nasdaq",
                    "new high",
                    "coronavirus"
                ],
                "sentiment_score": 0.85,
                "policy_related": "false",
                "investment_strategy": "false",
                "sector_focus": [
                    "finance",
                    "healthcare"
                ],
                "causal_factor": "true",
                "causal_impact": "positive",
                "affected_by_time_series": "false",
                "ts_effect_direction": "neutral"
            },
            "scores": {
                "News_content": "US STOCKS-Nasdaq hits new high as investors look beyond coronavirus",
                "Correlation": 9,
                "Sentiment": 7,
                "Importance": 7,
                "Impact": 7,
                "Duration": 5,
                "Entity_Density": 3,
                "Market_Scope": 9,
                "Time_Proximity": 7,
                "Headline_Structure": 8,
                "Source_Recency": 7
            }
        },
        {
            "time": "2023-10-03",
            "original_text": "Pharma Giant Slides On Alzheimer's Failure — Taking Biogen With It",
            "features": {
                "keywords": [
                    "Pharma",
                    "Alzheimer's",
                    "Biogen"
                ],
                "sentiment_score": -0.7,
                "policy_related": "false",
                "investment_strategy": "false",
                "sector_focus": [
                    "pharmaceuticals"
                ],
                "causal_factor": "true",
                "causal_impact": "negative",
                "affected_by_time_series": "true",
                "ts_effect_direction": "negative"
            },
            "scores": {
                "News_content": "Pharma Giant Slides On Alzheimer's Failure — Taking Biogen With It",
                "Correlation": 8,
                "Sentiment": 3,
                "Importance": 8,
                "Impact": 8,
                "Duration": 6,
                "Entity_Density": 7,
                "Market_Scope": 5,
                "Time_Proximity": 7,
                "Headline_Structure": 9,
                "Source_Recency": 7
            }
        },
        {
            "time": "2023-10-04",
            "original_text": "US STOCKS-Wall Street higher on U.S. growth optimism; Nasdaq hits record",
            "features": {
                "keywords": [
                    "Wall Street",
                    "U.S. growth",
                    "Nasdaq",
                    "record"
                ],
                "sentiment_score": 0.8,
                "policy_related": "false",
                "investment_strategy": "false",
                "sector_focus": [
                    "finance"
                ],
                "causal_factor": "true",
                "causal_impact": "positive",
                "affected_by_time_series": "false",
                "ts_effect_direction": "neutral"
            },
            "scores": {
                "News_content": "US STOCKS-Wall Street higher on U.S. growth optimism; Nasdaq hits record",
                "Correlation": 9,
                "Sentiment": 8,
                "Importance": 8,
                "Impact": 7,
                "Duration": 6,
                "Entity_Density": 4,
                "Market_Scope": 9,
                "Time_Proximity": 8,
                "Headline_Structure": 7,
                "Source_Recency": 8
            }
        },
        {
            "time": "2023-10-05",
            "original_text": "Eli Lilly Suffers Setback As Alzheimer's Study Fails To Meet Primary Endpoint",
            "features": {
                "keywords": [
                    "Eli Lilly",
                    "Alzheimer's",
                    "Setback"
                ],
                "sentiment_score": -0.6,
                "policy_related": "false",
                "investment_strategy": "false",
                "sector_focus": [
                    "pharmaceuticals"
                ],
                "causal_factor": "true",
                "causal_impact": "negative",
                "affected_by_time_series": "true",
                "ts_effect_direction": "negative"
            },
            "scores": {
                "News_content": "Eli Lilly Suffers Setback As Alzheimer's Study Fails To Meet Primary Endpoint",
                "Correlation": 10,
                "Sentiment": 2,
                "Importance": 9,
                "Impact": 9,
                "Duration": 7,
                "Entity_Density": 9,
                "Market_Scope": 4,
                "Time_Proximity": 8,
                "Headline_Structure": 8,
                "Source_Recency": 8
            }
        },
        {
            "time": "2023-10-06",
            "original_text": "Pharma Giants Slide On Alzheimer's Failures — Taking Biogen With Them",
            "features": {
                "keywords": [
                    "Pharma Giants",
                    "Alzheimer's",
                    "Failures",
                    "Biogen"
                ],
                "sentiment_score": -0.75,
                "policy_related": "false",
                "investment_strategy": "false",
                "sector_focus": [
                    "pharmaceuticals"
                ],
                "causal_factor": "true",
                "causal_impact": "negative",
                "affected_by_time_series": "true",
                "ts_effect_direction": "negative"
            },
            "scores": {
                "News_content": "Pharma Giants Slide On Alzheimer's Failures — Taking Biogen With Them",
                "Correlation": 8,
                "Sentiment": 3,
                "Importance": 8,
                "Impact": 8,
                "Duration": 6,
                "Entity_Density": 8,
                "Market_Scope": 6,
                "Time_Proximity": 7,
                "Headline_Structure": 9,
                "Source_Recency": 7
            }
        },
        {
            "time": "2023-10-07",
            "original_text": "US STOCKS-Wall St steady as investors weigh coronavirus risks",
            "features": {
                "keywords": [
                    "Wall St",
                    "steady",
                    "coronavirus risks"
                ],
                "sentiment_score": 0.2,
                "policy_related": "false",
                "investment_strategy": "false",
                "sector_focus": [
                    "finance",
                    "healthcare"
                ],
                "causal_factor": "true",
                "causal_impact": "neutral",
                "affected_by_time_series": "false",
                "ts_effect_direction": "neutral"
            },
            "scores": {
                "News_content": "US STOCKS-Wall St steady as investors weigh coronavirus risks",
                "Correlation": 8,
                "Sentiment": 5,
                "Importance": 6,
                "Impact": 5,
                "Duration": 5,
                "Entity_Density": 3,
                "Market_Scope": 9,
                "Time_Proximity": 7,
                "Headline_Structure": 6,
                "Source_Recency": 7
            }
        },
        {
            "time": "2023-10-08",
            "original_text": "Roche, Lilly drugs fail to halt gene-driven Alzheimer's disease",
            "features": {
                "keywords": [
                    "Roche",
                    "Lilly",
                    "Alzheimer's",
                    "fail"
                ],
                "sentiment_score": -0.65,
                "policy_related": "false",
                "investment_strategy": "false",
                "sector_focus": [
                    "pharmaceuticals"
                ],
                "causal_factor": "true",
                "causal_impact": "negative",
                "affected_by_time_series": "true",
                "ts_effect_direction": "negative"
            },
            "scores": {
                "News_content": "Roche, Lilly drugs fail to halt gene-driven Alzheimer's disease",
                "Correlation": 8,
                "Sentiment": 3,
                "Importance": 8,
                "Impact": 8,
                "Duration": 7,
                "Entity_Density": 8,
                "Market_Scope": 5,
                "Time_Proximity": 7,
                "Headline_Structure": 7,
                "Source_Recency": 7
            }
        },
        {
            "time": "2023-10-09",
            "original_text": "Eli Lilly Shares Slide After Alzheimer's Treatment Fails Clinical Trial",
            "features": {
                "keywords": [
                    "Eli Lilly",
                    "Shares",
                    "Slide",
                    "Alzheimer's",
                    "Clinical Trial"
                ],
                "sentiment_score": -0.7,
                "policy_related": "false",
                "investment_strategy": "false",
                "sector_focus": [
                    "pharmaceuticals"
                ],
                "causal_factor": "true",
                "causal_impact": "negative",
                "affected_by_time_series": "true",
                "ts_effect_direction": "negative"
            },
            "scores": {
                "News_content": "Eli Lilly Shares Slide After Alzheimer's Treatment Fails Clinical Trial",
                "Correlation": 10,
                "Sentiment": 2,
                "Importance": 9,
                "Impact": 9,
                "Duration": 7,
                "Entity_Density": 10,
                "Market_Scope": 4,
                "Time_Proximity": 8,
                "Headline_Structure": 8,
                "Source_Recency": 8
            }
        },
        {
            "time": "2023-10-10",
            "original_text": "Lilly and Biogen Stocks Get Hit as Another Alzheimer’s Treatment Fails a Trial",
            "features": {
                "keywords": [
                    "Lilly",
                    "Biogen",
                    "Stocks",
                    "Hit",
                    "Alzheimer’s",
                    "Trial"
                ],
                "sentiment_score": -0.7,
                "policy_related": "false",
                "investment_strategy": "false",
                "sector_focus": [
                    "pharmaceuticals"
                ],
                "causal_factor": "true",
                "causal_impact": "negative",
                "affected_by_time_series": "true",
                "ts_effect_direction": "negative"
            },
            "scores": {
                "News_content": "Lilly and Biogen Stocks Get Hit as Another Alzheimer’s Treatment Fails a Trial",
                "Correlation": 9,
                "Sentiment": 3,
                "Importance": 8,
                "Impact": 8,
                "Duration": 7,
                "Entity_Density": 9,
                "Market_Scope": 5,
                "Time_Proximity": 8,
                "Headline_Structure": 9,
                "Source_Recency": 8
            }
        },
        {
            "time": "2023-10-11",
            "original_text": "US STOCKS-Wall Street set for subdued open as investors weigh coronavirus risks",
            "features": {
                "keywords": [
                    "Wall Street",
                    "subdued open",
                    "coronavirus risks"
                ],
                "sentiment_score": 0.1,
                "policy_related": "false",
                "investment_strategy": "false",
                "sector_focus": [
                    "finance",
                    "healthcare"
                ],
                "causal_factor": "true",
                "causal_impact": "neutral",
                "affected_by_time_series": "false",
                "ts_effect_direction": "neutral"
            },
            "scores": {
                "News_content": "US STOCKS-Wall Street set for subdued open as investors weigh coronavirus risks",
                "Correlation": 8,
                "Sentiment": 5,
                "Importance": 6,
                "Impact": 5,
                "Duration": 5,
                "Entity_Density": 3,
                "Market_Scope": 9,
                "Time_Proximity": 7,
                "Headline_Structure": 7,
                "Source_Recency": 7
            }
        },
        {
            "time": "2023-10-12",
            "original_text": "Lilly's stock falls on failed Alzheimer's study",
            "features": {
                "keywords": [
                    "Lilly",
                    "stock",
                    "falls",
                    "failed",
                    "Alzheimer's"
                ],
                "sentiment_score": -0.6,
                "policy_related": "false",
                "investment_strategy": "false",
                "sector_focus": [
                    "pharmaceuticals"
                ],
                "causal_factor": "true",
                "causal_impact": "negative",
                "affected_by_time_series": "true",
                "ts_effect_direction": "negative"
            },
            "scores": {
                "News_content": "Lilly's stock falls on failed Alzheimer's study",
                "Correlation": 10,
                "Sentiment": 2,
                "Importance": 8,
                "Impact": 8,
                "Duration": 6,
                "Entity_Density": 9,
                "Market_Scope": 4,
                "Time_Proximity": 8,
                "Headline_Structure": 7,
                "Source_Recency": 8
            }
        },
        {
            "time": "2023-10-13",
            "original_text": "Lilly Announces Topline Results for Solanezumab from the Dominantly Inherited Alzheimer Network Trials Unit (DIAN-TU) Study",
            "features": {
                "keywords": [
                    "Lilly",
                    "Solanezumab",
                    "Topline Results",
                    "Alzheimer",
                    "DIAN-TU"
                ],
                "sentiment_score": -0.5,
                "policy_related": "false",
                "investment_strategy": "false",
                "sector_focus": [
                    "pharmaceuticals"
                ],
                "causal_factor": "true",
                "causal_impact": "negative",
                "affected_by_time_series": "true",
                "ts_effect_direction": "negative"
            },
            "scores": {
                "News_content": "Lilly Announces Topline Results for Solanezumab from the Dominantly Inherited Alzheimer Network Trials Unit (DIAN-TU) Study",
                "Correlation": 10,
                "Sentiment": 2,
                "Importance": 9,
                "Impact": 9,
                "Duration": 8,
                "Entity_Density": 10,
                "Market_Scope": 4,
                "Time_Proximity": 9,
                "Headline_Structure": 6,
                "Source_Recency": 9
            }
        },
        {
            "time": "2023-10-14",
            "original_text": "Roche and Eli Lilly drugs fail ‘inherited’ Alzheimer’s trial",
            "features": {
                "keywords": [
                    "Roche",
                    "Eli Lilly",
                    "drugs",
                    "fail",
                    "inherited",
                    "Alzheimer’s"
                ],
                "sentiment_score": -0.6,
                "policy_related": "false",
                "investment_strategy": "false",
                "sector_focus": [
                    "pharmaceuticals"
                ],
                "causal_factor": "true",
                "causal_impact": "negative",
                "affected_by_time_series": "true",
                "ts_effect_direction": "negative"
            },
            "scores": {
                "News_content": "Roche and Eli Lilly drugs fail ‘inherited’ Alzheimer’s trial",
                "Correlation": 8,
                "Sentiment": 3,
                "Importance": 8,
                "Impact": 8,
                "Duration": 7,
                "Entity_Density": 8,
                "Market_Scope": 5,
                "Time_Proximity": 7,
                "Headline_Structure": 7,
                "Source_Recency": 7
            }
        }
    ]
]